GAD2 and autism: The gene expression of GAD65 appears to be reduced in ASD patients in certain brain regions, such as the cerebellar dentate nuclei [69,70], and also in the cortex of mice whose mothers during pregnancy received the anti-epileptic drug valproate, which is associated with a high risk of autism [71].